Childhood Cancer and Its Warning Signs:@0.539148:0.035749:0.914549:0.035749:0.914549:0.019993:0.539148:0.019993:0.015644:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.013143:0.011738:0.013181:0.005330:0.004349:0.006523:0.007466:0.005330:0.017493:0.013143:0.006194:0.011738:0.003848:0.011738:0.012950:0.005330:0.009583:0.003848:0.012950:0.011738:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
121:@0.950254:0.038184:0.981863:0.038184:0.981863:0.018587:0.950254:0.018587:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
involves onco-chemotherapy, paediatric :@0.084242:0.096166:0.480476:0.096166:0.480476:0.080410:0.084242:0.080410:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.007466:0.009217:0.012604:0.011738:0.012450:0.012604:0.006377:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010300:0.005330:0.009217:0.013123:0.013143:0.012508:0.013181:0.003848:0.013143:0.006523:0.005792:0.003848:0.012450:0.005330
surgery and/or radiotherapy, as  well  as :@0.084242:0.112398:0.480484:0.112398:0.480484:0.096642:0.084242:0.096642:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.011007:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.011007:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.011007:0.013143:0.007466:0.005330:0.005688:0.015990:0.012508:0.003848:0.003848:0.005330:0.005688:0.013143:0.007466:0.005330
the  management  of  chemotherapy-  or :@0.084242:0.128630:0.480494:0.128630:0.480494:0.112874:0.084242:0.112874:0.006523:0.011738:0.012508:0.005330:0.006142:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.006142:0.012604:0.006042:0.005330:0.006144:0.012450:0.011738:0.012508:0.018049:0.012594:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006388:0.005330:0.006146:0.012604:0.005792:0.005330
radiation-related complications. Com-:@0.084242:0.144862:0.475150:0.144862:0.475150:0.129106:0.084242:0.129106:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006388:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.021782:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.021782:0.015644:0.012604:0.018049:0.006388
mon  complications are  neutropaenic :@0.084242:0.161094:0.480486:0.161094:0.480486:0.145338:0.084242:0.145338:0.018049:0.012604:0.011738:0.005330:0.013955:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.019300:0.013143:0.005715:0.012508:0.005330:0.013960:0.011738:0.012508:0.011699:0.006523:0.005705:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.012450:0.005330
sepsis, bleeding  disorders  and anaemia. :@0.084242:0.177327:0.480480:0.177327:0.480480:0.161571:0.084242:0.161571:0.007466:0.012508:0.013123:0.007466:0.003848:0.007466:0.005330:0.009833:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.005330:0.004489:0.013181:0.003848:0.007466:0.012604:0.005680:0.013181:0.012508:0.005792:0.007466:0.005330:0.004491:0.013143:0.011738:0.013181:0.009833:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
Children  with  amputations  will also need :@0.084242:0.193559:0.480482:0.193559:0.480482:0.177803:0.084242:0.177803:0.015644:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.005330:0.003102:0.015990:0.003848:0.006523:0.011738:0.005330:0.003108:0.013143:0.018049:0.013123:0.011699:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.003100:0.015990:0.003848:0.003848:0.003848:0.008447:0.013143:0.003848:0.007466:0.012604:0.008447:0.011738:0.012508:0.012508:0.013181:0.005330
extensive rehabilitation to be able to live :@0.084242:0.209500:0.480482:0.209500:0.480482:0.193744:0.084242:0.193744:0.012508:0.009236:0.006523:0.012508:0.011738:0.007466:0.003848:0.010660:0.012508:0.007397:0.005713:0.012508:0.011738:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007408:0.006523:0.012604:0.007391:0.013123:0.012508:0.007399:0.013143:0.013123:0.003848:0.012508:0.007408:0.006523:0.012604:0.007391:0.003848:0.003848:0.010660:0.012508:0.005330
as normal a life as possible and to adjust :@0.084242:0.225441:0.480492:0.225441:0.480492:0.209685:0.084242:0.209685:0.013143:0.007466:0.007197:0.011738:0.012604:0.006319:0.018049:0.013143:0.003848:0.007197:0.013143:0.007187:0.003848:0.003848:0.006042:0.012508:0.007183:0.013143:0.007466:0.007197:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.007197:0.013143:0.011738:0.013181:0.007183:0.006523:0.012604:0.007177:0.013143:0.013181:0.003906:0.011699:0.007466:0.006523:0.005330
to the use of artificial limbs.:@0.084242:0.241382:0.334740:0.241382:0.334740:0.225626:0.084242:0.225626:0.006523:0.012604:0.005330:0.006523:0.011738:0.012508:0.005330:0.011699:0.007466:0.012508:0.005330:0.012604:0.006042:0.005330:0.013143:0.005792:0.006523:0.003848:0.004686:0.004686:0.012450:0.003848:0.013143:0.003848:0.005330:0.003848:0.003848:0.018049:0.013123:0.007466:0.005330
LONG-TERM FOLLOW-UP:@0.084242:0.273922:0.355646:0.273922:0.355646:0.254325:0.084242:0.254325:0.010348:0.019756:0.017404:0.019756:0.009878:0.009878:0.012230:0.013641:0.021167:0.006585:0.011289:0.019756:0.010348:0.010348:0.019756:0.021167:0.009878:0.015052:0.013170
Survivors  of  childhood  cancer  need  life-:@0.084242:0.292156:0.475167:0.292156:0.475167:0.276400:0.084242:0.276400:0.009390:0.011507:0.005600:0.010468:0.003656:0.010468:0.012411:0.005600:0.007274:0.005330:0.005646:0.012411:0.005850:0.005330:0.005646:0.012257:0.011545:0.003656:0.003656:0.012989:0.011545:0.012411:0.012411:0.012989:0.005330:0.005644:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.005330:0.005644:0.011545:0.012315:0.012315:0.012989:0.005330:0.005646:0.003656:0.003656:0.005850:0.012315:0.006388
long follow-up care, initially in the first five :@0.084242:0.308097:0.480484:0.308097:0.480484:0.292341:0.084242:0.292341:0.003656:0.012411:0.011545:0.012758:0.007541:0.005850:0.012411:0.003656:0.003656:0.012411:0.015798:0.006196:0.011507:0.012931:0.007541:0.012257:0.012950:0.005521:0.012315:0.005138:0.007541:0.003656:0.011545:0.003656:0.006331:0.003656:0.012950:0.003656:0.003656:0.010122:0.007541:0.003656:0.011545:0.007541:0.006331:0.011545:0.012315:0.007541:0.004589:0.004589:0.005600:0.007274:0.006331:0.007541:0.004589:0.004589:0.010468:0.012506:0.005330
years to ensure that there is no recurrence :@0.084242:0.324038:0.480488:0.324038:0.480488:0.308282:0.084242:0.308282:0.010122:0.012315:0.012950:0.005600:0.007274:0.006004:0.006331:0.012411:0.006004:0.012315:0.011545:0.007274:0.011507:0.005519:0.012315:0.006004:0.006331:0.011545:0.012950:0.006331:0.006004:0.006331:0.011545:0.012315:0.005519:0.012315:0.006004:0.003656:0.007274:0.006004:0.011545:0.012411:0.006004:0.005521:0.012315:0.012257:0.011507:0.005600:0.005521:0.012315:0.011545:0.012257:0.012506:0.005330
of the cancer and thereafter for the po-:@0.084242:0.339979:0.475244:0.339979:0.475244:0.324223:0.084242:0.324223:0.012411:0.005850:0.008755:0.006331:0.011545:0.012315:0.008755:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.008755:0.012950:0.011545:0.012989:0.008755:0.006331:0.011545:0.012315:0.005519:0.012315:0.012950:0.005850:0.006331:0.012315:0.005600:0.008755:0.005850:0.012411:0.005600:0.008755:0.006331:0.011545:0.012315:0.008755:0.012931:0.012411:0.006388
tential complications of the different treat-:@0.084242:0.355920:0.475144:0.355920:0.475144:0.340164:0.084242:0.340164:0.006331:0.012315:0.011545:0.006331:0.003656:0.012950:0.003656:0.006042:0.012257:0.012411:0.017857:0.012931:0.003656:0.003656:0.012257:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.006042:0.012411:0.005850:0.006042:0.006331:0.011545:0.012315:0.006042:0.012989:0.003656:0.005905:0.005850:0.012315:0.005521:0.012315:0.011545:0.006331:0.006042:0.006331:0.005519:0.012315:0.012950:0.006331:0.006388
ment modalities. Up to 75% of children may :@0.084242:0.371861:0.480522:0.371861:0.480522:0.356105:0.084242:0.356105:0.017857:0.012315:0.011545:0.006331:0.004580:0.017857:0.012411:0.012989:0.012950:0.003656:0.003656:0.006331:0.003656:0.012315:0.007274:0.005138:0.004580:0.012411:0.012931:0.004580:0.006331:0.012411:0.004580:0.010468:0.010468:0.014720:0.004580:0.012411:0.005850:0.004580:0.012257:0.011545:0.003656:0.003656:0.012989:0.005521:0.012315:0.011545:0.004580:0.017857:0.012950:0.010318:0.005330
suffer at least one long-term late effect, de-:@0.084242:0.387802:0.475179:0.387802:0.475179:0.372046:0.084242:0.372046:0.007274:0.011507:0.005905:0.005850:0.012315:0.005600:0.004022:0.012950:0.006331:0.004022:0.003656:0.012315:0.012950:0.007274:0.006331:0.004022:0.012411:0.011545:0.012315:0.004022:0.003656:0.012411:0.011545:0.012758:0.006196:0.006331:0.012315:0.006131:0.017857:0.004022:0.003656:0.012950:0.006331:0.012315:0.004022:0.012315:0.005905:0.005850:0.012315:0.012257:0.006331:0.005138:0.004022:0.012989:0.012315:0.006388
pending on the type of the cancer, the po-:@0.084242:0.403744:0.475186:0.403744:0.475186:0.387988:0.084242:0.387988:0.012931:0.012315:0.011545:0.012989:0.003656:0.011545:0.012758:0.004618:0.012411:0.011545:0.004618:0.006331:0.011545:0.012315:0.004618:0.006331:0.010122:0.012931:0.012315:0.004618:0.012411:0.005850:0.004618:0.006331:0.011545:0.012315:0.004618:0.012257:0.012950:0.011545:0.012257:0.012315:0.003575:0.005138:0.004618:0.006331:0.011545:0.012315:0.004618:0.012931:0.012411:0.006388
sition of the cancer and the treatment re-:@0.084242:0.419685:0.475165:0.419685:0.475165:0.403929:0.084242:0.403929:0.007274:0.003656:0.006331:0.003656:0.012411:0.011545:0.006754:0.012411:0.005850:0.006754:0.006331:0.011545:0.012315:0.006754:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.006754:0.012950:0.011545:0.012989:0.006754:0.006331:0.011545:0.012315:0.006754:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.006754:0.005521:0.012315:0.006388
ceived.:@0.084242:0.435626:0.153573:0.435626:0.153573:0.419870:0.084242:0.419870:0.012257:0.012315:0.003656:0.010468:0.012315:0.012989:0.005330
17,18:@0.153382:0.430001:0.180900:0.430001:0.180900:0.420816:0.153382:0.420816:0.006103:0.006103:0.002995:0.006103:0.006215
 Radiotherapy, in particular, can :@0.180795:0.435620:0.480488:0.435620:0.480488:0.419864:0.180795:0.419864:0.005311:0.011488:0.012950:0.012989:0.003656:0.012411:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.005138:0.005311:0.003656:0.011545:0.005311:0.012931:0.012950:0.005600:0.006331:0.003656:0.012257:0.011507:0.003656:0.012950:0.003575:0.005138:0.005311:0.012257:0.012950:0.011734:0.005330
cause long-term effects such as the need :@0.084237:0.451561:0.480532:0.451561:0.480532:0.435805:0.084237:0.435805:0.012257:0.012950:0.011507:0.007274:0.012315:0.006812:0.003656:0.012411:0.011545:0.012758:0.006196:0.006331:0.012315:0.006131:0.017857:0.006802:0.012315:0.005904:0.005850:0.012315:0.012257:0.006331:0.007274:0.006812:0.007274:0.011507:0.012257:0.011545:0.006812:0.012950:0.007274:0.006812:0.006331:0.011545:0.012315:0.006812:0.011545:0.012315:0.012315:0.013181:0.005330
for joint replacement, congestive heart :@0.084237:0.467502:0.480511:0.467502:0.480511:0.451746:0.084237:0.451746:0.005850:0.012411:0.005600:0.013508:0.003714:0.012411:0.003656:0.011545:0.006331:0.013508:0.005521:0.012315:0.012931:0.003656:0.012950:0.012257:0.012315:0.017857:0.012315:0.011545:0.006331:0.005138:0.013508:0.012257:0.012411:0.011545:0.012758:0.012315:0.007274:0.006331:0.003656:0.010468:0.012315:0.013508:0.011545:0.012315:0.012950:0.005600:0.006521:0.005330
failure (if the chest was irradiated) and :@0.084237:0.483444:0.480496:0.483444:0.480496:0.467688:0.084237:0.467688:0.005850:0.012950:0.003656:0.003656:0.011507:0.005521:0.012315:0.011584:0.006908:0.003656:0.005850:0.011584:0.006331:0.011545:0.012315:0.011584:0.012257:0.011545:0.012315:0.007274:0.006331:0.011584:0.015798:0.012950:0.007274:0.011584:0.003656:0.005600:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.012315:0.012989:0.006908:0.011584:0.012950:0.011545:0.013183:0.005330
secondary cancers. Onco-chemotherapy :@0.084237:0.499385:0.480500:0.499385:0.480500:0.483629:0.084237:0.483629:0.007274:0.012315:0.012257:0.012411:0.011545:0.012989:0.012950:0.005600:0.010122:0.008409:0.012257:0.012950:0.011545:0.012257:0.012315:0.005600:0.007274:0.005138:0.008409:0.016529:0.011545:0.012257:0.012411:0.006196:0.012257:0.011545:0.012315:0.017857:0.012411:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010318:0.005330
can also damage the important target or-:@0.084237:0.515326:0.475162:0.515326:0.475162:0.499570:0.084237:0.499570:0.012257:0.012950:0.011545:0.005927:0.012950:0.003656:0.007274:0.012411:0.005927:0.012989:0.012950:0.017857:0.012950:0.012758:0.012315:0.005927:0.006331:0.011545:0.012315:0.005927:0.003656:0.017857:0.012931:0.012411:0.005600:0.006331:0.012950:0.011545:0.006331:0.005927:0.006331:0.012950:0.005615:0.012758:0.012315:0.006331:0.005927:0.012411:0.005600:0.006388
gans such as the heart, kidneys and liver, as :@0.084237:0.531267:0.480455:0.531267:0.480455:0.515511:0.084237:0.515511:0.012758:0.012950:0.011545:0.007274:0.004426:0.007274:0.011507:0.012257:0.011545:0.004426:0.012950:0.007274:0.004426:0.006331:0.011545:0.012315:0.004426:0.011545:0.012315:0.012950:0.005600:0.006331:0.005138:0.004426:0.009467:0.003656:0.012989:0.011545:0.012315:0.010122:0.007274:0.004426:0.012950:0.011545:0.012989:0.004426:0.003656:0.003656:0.010468:0.012315:0.003575:0.005138:0.004426:0.012950:0.007468:0.005330
well as cause hearing loss. :@0.084237:0.547208:0.328383:0.547208:0.328383:0.531452:0.084237:0.531452:0.015798:0.012315:0.003656:0.003656:0.005138:0.012950:0.007274:0.005138:0.012257:0.012950:0.011507:0.007274:0.012315:0.005138:0.011545:0.012315:0.012950:0.005600:0.003656:0.011545:0.012758:0.005138:0.003656:0.012411:0.007274:0.007274:0.005328:0.005330
As the current treatment aims are to mini-:@0.084237:0.579090:0.475133:0.579090:0.475133:0.563334:0.084237:0.563334:0.014239:0.007466:0.005990:0.006523:0.011738:0.012508:0.005986:0.012450:0.011699:0.005792:0.005707:0.012508:0.011738:0.006523:0.005984:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005982:0.013143:0.003848:0.018049:0.007466:0.005992:0.013143:0.005713:0.012508:0.005990:0.006523:0.012604:0.005986:0.018049:0.003848:0.011738:0.003848:0.006388
mise long-term side effects, survivors in re-:@0.084237:0.595032:0.475156:0.595032:0.475156:0.579276:0.084237:0.579276:0.018049:0.003848:0.007466:0.012508:0.006004:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006317:0.018049:0.006004:0.007466:0.003848:0.013181:0.012508:0.006004:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005994:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.012604:0.005792:0.007466:0.006004:0.003848:0.011738:0.006004:0.005713:0.012508:0.006388
cent decades suffer fewer long-term ad-:@0.084237:0.610973:0.475154:0.610973:0.475154:0.595217:0.084237:0.595217:0.012450:0.012508:0.011738:0.006523:0.007429:0.013181:0.012508:0.012450:0.013143:0.013181:0.012508:0.007466:0.007447:0.007466:0.011699:0.006098:0.006042:0.012508:0.005792:0.007431:0.006042:0.012508:0.015990:0.012508:0.005792:0.007429:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006313:0.018049:0.007447:0.013143:0.013181:0.006388
verse effects. It is important that a survivor :@0.084237:0.626914:0.480490:0.626914:0.480490:0.611158:0.084237:0.611158:0.010660:0.012508:0.005792:0.007466:0.012508:0.005705:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005702:0.004349:0.006523:0.005705:0.003848:0.007466:0.005715:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005698:0.006523:0.011738:0.013143:0.006523:0.005705:0.013143:0.005715:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.012604:0.005792:0.005330
of childhood cancer should be provided :@0.084237:0.642855:0.480477:0.642855:0.480477:0.627099:0.084237:0.627099:0.012604:0.006042:0.007601:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.007601:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007601:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.007601:0.013123:0.012508:0.007601:0.013123:0.005715:0.012604:0.010660:0.003848:0.013181:0.012508:0.013181:0.005330
with  a  cancer-treatment  record  that  in-:@0.084237:0.658796:0.475152:0.658796:0.475152:0.643040:0.084237:0.643040:0.015990:0.003848:0.006523:0.011738:0.005330:0.004662:0.013143:0.005330:0.004666:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006388:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004653:0.005713:0.012508:0.012450:0.012604:0.005667:0.013181:0.005330:0.004664:0.006523:0.011738:0.013143:0.006523:0.005330:0.004659:0.003848:0.011738:0.006388
cludes the following information::@0.084237:0.674737:0.387395:0.674737:0.387395:0.658981:0.084237:0.658981:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.005330:0.006523:0.011738:0.012508:0.005330:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330:0.003848:0.011738:0.006042:0.012604:0.006306:0.018049:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
19:@0.387395:0.669109:0.399825:0.669109:0.399825:0.659923:0.387395:0.659923:0.006215:0.006215
n   :@0.084242:0.687549:0.107051:0.687549:0.107051:0.679109:0.084242:0.679109:0.009762:0.003566:0.005914:0.003566
type and stage of cancer:@0.103485:0.690668:0.344650:0.690668:0.344650:0.674913:0.103485:0.674913:0.006523:0.010314:0.013123:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.012604:0.006042:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
n   :@0.084242:0.703490:0.107051:0.703490:0.107051:0.695049:0.084242:0.695049:0.009762:0.003566:0.005914:0.003566
date of diagnosis and dates of relapses:@0.103485:0.706609:0.470995:0.706609:0.470995:0.690853:0.103485:0.690853:0.013181:0.013143:0.006523:0.012508:0.005330:0.012604:0.006042:0.005330:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.013181:0.013143:0.006523:0.012508:0.007466:0.005330:0.012604:0.006042:0.005330:0.005696:0.012508:0.003848:0.013143:0.013123:0.007466:0.012508:0.007466
n   :@0.084242:0.719430:0.107051:0.719430:0.107051:0.710990:0.084242:0.710990:0.009762:0.003566:0.005914:0.003566
imaging done with dates:@0.103485:0.722549:0.336953:0.722549:0.336953:0.706793:0.103485:0.706793:0.003848:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.005330:0.013181:0.012604:0.011738:0.012508:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.013181:0.013143:0.006523:0.012508:0.007466
n   :@0.084242:0.735371:0.107051:0.735371:0.107051:0.726931:0.084242:0.726931:0.009762:0.003566:0.005914:0.003566
contact details of treating doctors:@0.103485:0.738490:0.422947:0.738490:0.422947:0.722734:0.103485:0.722734:0.012450:0.012604:0.011738:0.006523:0.013143:0.012450:0.006523:0.005330:0.013181:0.012508:0.006523:0.013143:0.003848:0.003848:0.007466:0.005330:0.012604:0.006042:0.005330:0.006523:0.005696:0.012508:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.013181:0.012604:0.012450:0.006523:0.012604:0.005792:0.007466
n   :@0.084242:0.751605:0.107051:0.751605:0.107051:0.743165:0.084242:0.743165:0.009762:0.003566:0.005914:0.003566
list of onco-chemotherapy medicines :@0.103485:0.754725:0.456987:0.754725:0.456987:0.738969:0.103485:0.738969:0.003848:0.003848:0.007466:0.006523:0.005330:0.012604:0.006042:0.005330:0.012604:0.011738:0.012450:0.012604:0.006388:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010295:0.005330:0.018049:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.007466:0.005330
received, as well as total doses:@0.103485:0.770957:0.392119:0.770957:0.392119:0.755201:0.103485:0.755201:0.005713:0.012508:0.012450:0.012508:0.003848:0.010660:0.012508:0.013181:0.005330:0.005330:0.013143:0.007466:0.005330:0.015990:0.012508:0.003848:0.003848:0.005330:0.013143:0.007466:0.005330:0.006523:0.012604:0.006523:0.013143:0.003848:0.005330:0.013181:0.012604:0.007466:0.012508:0.007466
n   :@0.084242:0.784074:0.107051:0.784074:0.107051:0.775634:0.084242:0.775634:0.009762:0.003566:0.005914:0.003566
types of surgery done, radiotherapy :@0.103485:0.787193:0.442305:0.787193:0.442305:0.771437:0.103485:0.771437:0.006523:0.010314:0.013123:0.012508:0.007466:0.005330:0.012604:0.006042:0.005330:0.007466:0.011699:0.005792:0.012950:0.012508:0.005792:0.010314:0.005330:0.013181:0.012604:0.011738:0.012508:0.005330:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
doses and dates with exact description :@0.103485:0.803426:0.474613:0.803426:0.474613:0.787670:0.103485:0.787670:0.013181:0.012604:0.007466:0.012508:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.013181:0.013143:0.006523:0.012508:0.007466:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.012508:0.009236:0.013143:0.012450:0.006523:0.005330:0.013181:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.006523:0.003848:0.012604:0.011738:0.005330
of sites:@0.103485:0.819658:0.165272:0.819658:0.165272:0.803902:0.103485:0.803902:0.012604:0.006042:0.005330:0.007466:0.003848:0.006523:0.012508:0.007466
n   :@0.084242:0.832778:0.107051:0.832778:0.107051:0.824338:0.084242:0.824338:0.009762:0.003566:0.005914:0.003566
any serious complications during :@0.103485:0.835897:0.412287:0.835897:0.412287:0.820141:0.103485:0.820141:0.013143:0.011738:0.010314:0.005330:0.007466:0.012508:0.005792:0.003848:0.012604:0.011699:0.007466:0.005330:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330
treatment and the date of therapy :@0.103485:0.852129:0.434660:0.852129:0.434660:0.836373:0.103485:0.836373:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.013143:0.011738:0.013181:0.005330:0.006523:0.011738:0.012508:0.005330:0.013181:0.013143:0.006523:0.012508:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
completed.:@0.103485:0.868361:0.213609:0.868361:0.213609:0.852605:0.103485:0.852605:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.013181:0.005330
CONCLUSION:@0.084242:0.901482:0.239464:0.901482:0.239464:0.881885:0.084242:0.881885:0.018344:0.019756:0.017404:0.018344:0.010348:0.015052:0.012230:0.006585:0.019756:0.017404
As the majority of children in LMICs are di-:@0.084242:0.920009:0.475196:0.920009:0.475196:0.904253:0.084242:0.904253:0.013855:0.007081:0.007466:0.006138:0.011353:0.012123:0.007466:0.017665:0.012758:0.003521:0.012219:0.005407:0.003464:0.006138:0.009929:0.007466:0.012219:0.005657:0.007466:0.012065:0.011353:0.003464:0.003464:0.012796:0.005328:0.012123:0.011353:0.007456:0.003464:0.011353:0.007456:0.008505:0.017299:0.003964:0.015259:0.007081:0.007456:0.012758:0.005328:0.012123:0.007466:0.012796:0.003464:0.006388
agnosed late, it is important to sensitise :@0.084242:0.936241:0.480461:0.936241:0.480461:0.920486:0.084242:0.920486:0.012758:0.012565:0.011353:0.012219:0.007081:0.012123:0.012796:0.012315:0.003464:0.012758:0.006138:0.012123:0.004945:0.012315:0.003464:0.006138:0.012315:0.003464:0.007081:0.012315:0.003464:0.017665:0.012738:0.012219:0.005407:0.006138:0.012758:0.011353:0.006138:0.012315:0.006138:0.012219:0.012315:0.007081:0.012123:0.011353:0.007081:0.003464:0.006138:0.003464:0.007081:0.012506:0.005330
the health-care community to the possibil-:@0.523643:0.096163:0.914569:0.096163:0.914569:0.080407:0.523643:0.080407:0.006138:0.011353:0.012123:0.007485:0.011353:0.012123:0.012758:0.003464:0.006138:0.011353:0.006004:0.012065:0.012758:0.005328:0.012123:0.007485:0.012065:0.012219:0.017665:0.017665:0.011315:0.011353:0.003464:0.006138:0.009929:0.007485:0.006138:0.012219:0.007485:0.006138:0.011353:0.012123:0.007485:0.012738:0.012219:0.007081:0.007081:0.003464:0.012738:0.003464:0.003464:0.006388
ity of a child having developed a cancer. :@0.523643:0.112554:0.919873:0.112554:0.919873:0.096798:0.523643:0.096798:0.003464:0.006138:0.009929:0.007531:0.012219:0.005657:0.007533:0.012758:0.007531:0.012065:0.011353:0.003464:0.003464:0.012796:0.007533:0.011353:0.012758:0.010275:0.003464:0.011353:0.012565:0.007531:0.012796:0.012123:0.010275:0.012123:0.003464:0.012219:0.012738:0.012123:0.012796:0.007533:0.012758:0.007531:0.012065:0.012758:0.011353:0.012065:0.012123:0.003993:0.005328:0.005330
The warning signs are important to share in :@0.523643:0.128945:0.919896:0.128945:0.919896:0.113189:0.523643:0.113189:0.007812:0.011353:0.012123:0.006415:0.015606:0.012758:0.005805:0.011353:0.003464:0.011353:0.012565:0.006415:0.007081:0.003464:0.012565:0.011353:0.007081:0.006413:0.012758:0.005328:0.012123:0.006413:0.003464:0.017665:0.012738:0.012219:0.005407:0.006138:0.012758:0.011353:0.006138:0.006413:0.006138:0.012219:0.006413:0.007081:0.011353:0.012758:0.005328:0.012123:0.006413:0.003464:0.011736:0.005330
childhood-cancer  awareness campaigns, :@0.523643:0.145336:0.919888:0.145336:0.919888:0.129580:0.523643:0.129580:0.012065:0.011353:0.003464:0.003464:0.012796:0.011353:0.012219:0.012219:0.012796:0.006004:0.012065:0.012758:0.011353:0.012065:0.012123:0.005407:0.005330:0.006379:0.012758:0.015606:0.012758:0.005328:0.012123:0.011353:0.012123:0.007081:0.007081:0.011719:0.012065:0.012758:0.017665:0.012738:0.012758:0.003464:0.012565:0.011353:0.007081:0.005328:0.005330
as this may assist in early identification and :@0.523643:0.161727:0.919855:0.161727:0.919855:0.145971:0.523643:0.145971:0.012758:0.007081:0.006706:0.006138:0.011353:0.003464:0.007081:0.006706:0.017665:0.012758:0.009929:0.006708:0.012758:0.007081:0.007081:0.003464:0.007081:0.006138:0.006706:0.003464:0.011353:0.006706:0.012123:0.012758:0.005407:0.003464:0.009929:0.006706:0.003464:0.012796:0.012123:0.011353:0.006138:0.003464:0.004493:0.004493:0.012065:0.012758:0.006138:0.003464:0.012219:0.011353:0.006706:0.012758:0.011353:0.013181:0.005330
diagnosis. Country policy-makers should en-:@0.523643:0.178118:0.914571:0.178118:0.914571:0.162362:0.523643:0.162362:0.012796:0.003464:0.012758:0.012565:0.011353:0.012219:0.007081:0.003464:0.007081:0.004945:0.004830:0.015259:0.012219:0.011315:0.011353:0.006138:0.005407:0.009929:0.004830:0.012738:0.012219:0.003464:0.003464:0.012065:0.009929:0.006004:0.017665:0.012758:0.009275:0.012123:0.005407:0.007081:0.004820:0.007081:0.011353:0.012219:0.011315:0.003464:0.012796:0.004820:0.012123:0.011353:0.006388
sure that there is an effective referral system :@0.523643:0.194509:0.919894:0.194509:0.919894:0.178753:0.523643:0.178753:0.007081:0.011315:0.005328:0.012123:0.004945:0.006138:0.011353:0.012758:0.006138:0.004945:0.006138:0.011353:0.012123:0.005328:0.012123:0.004945:0.003464:0.007081:0.004945:0.012758:0.011353:0.004945:0.012123:0.005713:0.005657:0.012123:0.012065:0.006138:0.003464:0.010275:0.012123:0.004945:0.005328:0.012123:0.005657:0.012123:0.005407:0.005407:0.012758:0.003464:0.004945:0.007081:0.009929:0.007081:0.006138:0.012123:0.018049:0.005330
for these children with adequate treatment :@0.523643:0.210900:0.919894:0.210900:0.919894:0.195144:0.523643:0.195144:0.005657:0.012219:0.005407:0.005484:0.006138:0.011353:0.012123:0.007081:0.012123:0.005484:0.012065:0.011353:0.003464:0.003464:0.012796:0.005328:0.012123:0.011353:0.005484:0.015606:0.003464:0.006138:0.011353:0.005484:0.012758:0.012796:0.012123:0.012738:0.011315:0.012758:0.006138:0.012123:0.005484:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006519:0.005330
facilities, as childhood cancer is curable in :@0.523643:0.227290:0.919842:0.227290:0.919842:0.211535:0.523643:0.211535:0.005657:0.012758:0.012065:0.003464:0.003464:0.003464:0.006138:0.003464:0.012123:0.007081:0.004945:0.007216:0.012758:0.007081:0.007216:0.012065:0.011353:0.003464:0.003464:0.012796:0.011353:0.012219:0.012219:0.012796:0.007216:0.012065:0.012758:0.011353:0.012065:0.012123:0.005407:0.007216:0.003464:0.007081:0.007216:0.012065:0.011315:0.005407:0.012758:0.012738:0.003464:0.012123:0.007216:0.003464:0.011736:0.005330
the majority of patients.:@0.523643:0.243681:0.734193:0.243681:0.734193:0.227925:0.523643:0.227925:0.006138:0.011353:0.012123:0.004945:0.017665:0.012758:0.003521:0.012219:0.005407:0.003464:0.006138:0.009929:0.004945:0.012219:0.005657:0.004945:0.012738:0.012758:0.006138:0.003464:0.012123:0.011353:0.006138:0.007081:0.005330
REFERENCES:@0.523643:0.273526:0.634479:0.273526:0.634479:0.257493:0.523643:0.257493:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1. :@0.523636:0.290495:0.542588:0.290495:0.542588:0.276490:0.523636:0.276490:0.009476:0.004738:0.004738
 Siegel RL, Miller KD, Jemal A. Cancer Sta-:@0.559983:0.290495:0.914556:0.290495:0.914556:0.276490:0.559983:0.276490:0.000000:0.008518:0.003421:0.011118:0.011511:0.011118:0.003421:0.007098:0.010382:0.007902:0.004738:0.007098:0.015719:0.003421:0.003421:0.003421:0.011118:0.005148:0.007098:0.010109:0.012726:0.004738:0.007098:0.008244:0.011118:0.016044:0.011682:0.003421:0.007098:0.012657:0.004738:0.007098:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.007098:0.008518:0.005798:0.011682:0.005679
tistics, 2017. :@0.559983:0.304689:0.659821:0.304689:0.659821:0.290683:0.559983:0.290683:0.005798:0.003421:0.006636:0.005798:0.003421:0.011067:0.006636:0.004738:0.004943:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
CA: A Cancer Journal for Clini-:@0.660026:0.304689:0.914541:0.304689:0.914541:0.290683:0.660026:0.290683:0.013906:0.012657:0.004738:0.004931:0.012657:0.004943:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004931:0.008244:0.011203:0.010399:0.005148:0.010434:0.011682:0.003421:0.004931:0.005371:0.011203:0.005148:0.004929:0.013906:0.003421:0.003421:0.010434:0.003421:0.005679
cians:@0.559983:0.318882:0.603222:0.318882:0.603222:0.304877:0.559983:0.304877:0.011067:0.003421:0.011682:0.010434:0.006636
 2017; ]67(1):7-30.:@0.603222:0.318882:0.745975:0.318882:0.745975:0.304877:0.603222:0.304877:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738:0.006004:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.005679:0.009476:0.009476:0.004738
2. :@0.523636:0.333075:0.542588:0.333075:0.542588:0.319070:0.523636:0.319070:0.009476:0.004738:0.004738
  Kruger M, Hendricks M, Davidson A, :@0.559983:0.333075:0.868540:0.333075:0.868540:0.319070:0.559983:0.319070:0.004738:-0.004738:0.010109:0.005148:0.010399:0.011511:0.011118:0.005148:0.006980:0.015719:0.004738:0.006996:0.011682:0.011118:0.010434:0.011716:0.005148:0.003421:0.011067:0.008586:0.006636:0.006996:0.015719:0.004738:0.006996:0.012726:0.011682:0.009476:0.003431:0.011716:0.006636:0.011203:0.010434:0.006996:0.012657:0.004738:0.004738
et al:@0.870798:0.333075:0.909813:0.333075:0.909813:0.319070:0.870798:0.319070:0.011118:0.005798:0.006996:0.011682:0.003421
. :@0.909813:0.333075:0.919289:0.333075:0.919289:0.319070:0.909813:0.319070:0.004738:0.004738
Childhood cancer in Africa. :@0.559983:0.347269:0.800006:0.347269:0.800006:0.333264:0.559983:0.333264:0.013906:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.006457:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.006455:0.003421:0.010434:0.006465:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.004738:0.004738
Pediatr Blood :@0.801719:0.347269:0.919294:0.347269:0.919294:0.333264:0.801719:0.333264:0.010126:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.006465:0.009818:0.003421:0.011203:0.011203:0.011716:0.004738
Cancer.:@0.559983:0.361462:0.628075:0.361462:0.628075:0.347457:0.559983:0.347457:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
 2014;61:587-592.:@0.628058:0.361462:0.766398:0.361462:0.766398:0.347457:0.628058:0.347457:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
3. :@0.523636:0.376244:0.542588:0.376244:0.542588:0.362238:0.523636:0.362238:0.009476:0.004738:0.004738
  Steliarova-Foucher  E,  Colombet  M,  Ries :@0.559983:0.376244:0.919289:0.376244:0.919289:0.362238:0.559983:0.362238:0.004738:-0.004738:0.008518:0.005798:0.011118:0.003421:0.003421:0.011682:0.005083:0.011203:0.009476:0.011682:0.005679:0.008296:0.011203:0.010399:0.011067:0.010434:0.011118:0.005148:0.004738:0.007642:0.009168:0.004738:0.004738:0.007651:0.013906:0.011203:0.003421:0.011203:0.016044:0.011665:0.011118:0.005798:0.004738:0.007651:0.015719:0.004738:0.004738:0.007647:0.010382:0.003421:0.011118:0.006636:0.004738
LAG, :@0.559983:0.391025:0.604933:0.391025:0.604933:0.377020:0.559983:0.377020:0.007902:0.012657:0.014915:0.004738:0.004738
et al:@0.614682:0.391025:0.661189:0.391025:0.661189:0.377020:0.614682:0.377020:0.011118:0.005798:0.014487:0.011682:0.003421
. International incidence of :@0.661189:0.391025:0.919289:0.391025:0.919289:0.377020:0.661189:0.377020:0.004738:0.014487:0.003866:0.010434:0.005798:0.011118:0.005502:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.014487:0.003421:0.010434:0.011067:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.014487:0.011203:0.005371:0.004738
childhood  cancer,  2001-10:  a  population :@0.559983:0.405806:0.919282:0.405806:0.919282:0.391801:0.559983:0.391801:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.004738:0.004416:0.011067:0.011682:0.010434:0.011067:0.011118:0.003347:0.004738:0.004738:0.004418:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738:0.004738:0.004440:0.011682:0.004738:0.004421:0.011665:0.011203:0.011665:0.010399:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738
based registry study. :@0.559983:0.420588:0.748777:0.420588:0.748777:0.406583:0.559983:0.406583:0.011665:0.011682:0.006636:0.011118:0.011716:0.012452:0.005077:0.011118:0.011511:0.003421:0.006636:0.005798:0.005148:0.009168:0.012452:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Lancet Oncology:@0.756491:0.420588:0.909815:0.420588:0.909815:0.406583:0.756491:0.406583:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.012452:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
. :@0.909815:0.420588:0.919291:0.420588:0.919291:0.406583:0.909815:0.406583:0.004738:0.004738
2017;18:719-731.:@0.559983:0.435357:0.693585:0.435357:0.693585:0.421352:0.559983:0.421352:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
4. :@0.523636:0.450139:0.542588:0.450139:0.542588:0.436134:0.523636:0.436134:0.009476:0.004738:0.004738
  Ribeiro R, Steliarova-Foucher E, Magrath I,:@0.559983:0.450139:0.914558:0.450139:0.914558:0.436134:0.559983:0.436134:0.004738:-0.004738:0.010382:0.003421:0.011665:0.011118:0.003421:0.005083:0.011203:0.006790:0.010382:0.004738:0.006790:0.008518:0.005798:0.011118:0.003421:0.003421:0.011682:0.005087:0.011203:0.009476:0.011682:0.005679:0.008296:0.011203:0.010399:0.011067:0.010434:0.011118:0.005148:0.006775:0.009168:0.004738:0.006790:0.015719:0.011682:0.011511:0.005148:0.011682:0.005798:0.010434:0.006780:0.003866:0.004738
 :@0.914558:0.450139:0.919296:0.450139:0.919296:0.436134:0.914558:0.436134:0.004738
et al.:@0.559983:0.464920:0.604557:0.464920:0.604557:0.450915:0.559983:0.450915:0.011118:0.005798:0.007817:0.011682:0.003421:0.004738
 Baseline status of paediatric oncol-:@0.604557:0.464920:0.914539:0.464920:0.914539:0.450915:0.604557:0.450915:0.007817:0.009818:0.011682:0.006636:0.011118:0.003421:0.003421:0.010434:0.011118:0.007817:0.006636:0.005798:0.011682:0.005798:0.010399:0.006636:0.007817:0.011203:0.005371:0.007817:0.011665:0.011682:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.007817:0.011203:0.010434:0.011067:0.011203:0.003421:0.005679
ogy care in ten low-income or mid-income :@0.559983:0.479702:0.919275:0.479702:0.919275:0.465696:0.559983:0.465696:0.011203:0.011511:0.009168:0.004704:0.011067:0.011682:0.005078:0.011118:0.004704:0.003421:0.010434:0.004704:0.005798:0.011118:0.010434:0.004704:0.003421:0.011203:0.014214:0.005679:0.003421:0.010434:0.011067:0.011203:0.016044:0.011118:0.004704:0.011203:0.005148:0.004704:0.016044:0.003421:0.011716:0.005679:0.003421:0.010434:0.011067:0.011203:0.016044:0.011118:0.004738
countries  receiving  My Child Matters  sup-:@0.559983:0.494483:0.914539:0.494483:0.914539:0.480478:0.559983:0.480478:0.011067:0.011203:0.010399:0.010434:0.005798:0.005148:0.003421:0.011118:0.006636:0.004738:0.002980:0.005078:0.011118:0.011067:0.011118:0.003421:0.009476:0.003421:0.010434:0.011511:0.004738:0.002985:0.015719:0.009168:0.007731:0.013906:0.010434:0.003421:0.003421:0.011716:0.007731:0.015719:0.011682:0.005798:0.005798:0.011118:0.005148:0.006636:0.004738:0.002983:0.006636:0.010399:0.011665:0.005679
port:  a descriptive study. :@0.559983:0.509264:0.784929:0.509264:0.784929:0.495259:0.559983:0.495259:0.011665:0.011203:0.005148:0.005798:0.004738:0.004738:0.005566:0.011682:0.010314:0.011716:0.011118:0.006636:0.011067:0.005148:0.003421:0.011665:0.005798:0.003421:0.009476:0.011118:0.010314:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Lancet Oncol:@0.790505:0.509264:0.909808:0.509264:0.909808:0.495259:0.790505:0.495259:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.010314:0.014864:0.010434:0.011067:0.011203:0.003421
. :@0.909808:0.509264:0.919284:0.509264:0.919284:0.495259:0.909808:0.495259:0.004738:0.004738
2008;9:721-729.:@0.559983:0.524046:0.684109:0.524046:0.684109:0.510040:0.559983:0.510040:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
5. :@0.523636:0.538827:0.542588:0.538827:0.542588:0.524822:0.523636:0.524822:0.009476:0.004738:0.004738
  O’Leary M,  Krailo M,  Anderson  JR,  Rea-:@0.559983:0.538827:0.914563:0.538827:0.914563:0.524822:0.559983:0.524822:0.004738:-0.004738:0.014864:0.006004:0.007902:0.011118:0.011682:0.005148:0.009168:0.010211:0.015719:0.004738:0.004738:0.005463:0.010109:0.005148:0.011682:0.003421:0.003421:0.011203:0.010211:0.015719:0.004738:0.004738:0.005463:0.012657:0.010434:0.011716:0.011118:0.005148:0.006636:0.011203:0.010434:0.004738:0.005460:0.008244:0.010382:0.004738:0.004738:0.005463:0.010382:0.011118:0.011682:0.005679
man GH, Children’s Oncology Group. :@0.559983:0.553609:0.919306:0.553609:0.919306:0.539603:0.559983:0.539603:0.016044:0.011682:0.010434:0.015514:0.014915:0.011682:0.004738:0.015514:0.013906:0.010434:0.003421:0.003421:0.011716:0.005077:0.011118:0.010434:0.006004:0.006636:0.015514:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.015514:0.014915:0.005078:0.011203:0.010399:0.011665:0.004738:0.004738
Progress in childhood  cancer:  50 years of :@0.559983:0.568390:0.919302:0.568390:0.919302:0.554385:0.559983:0.554385:0.010126:0.005075:0.011203:0.011511:0.005071:0.011118:0.006636:0.006636:0.007372:0.003421:0.010434:0.007372:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.004738:0.002622:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004738:0.002617:0.009476:0.009476:0.007372:0.009168:0.011118:0.011682:0.005148:0.006636:0.007372:0.011203:0.005371:0.004738
research collaboration, a report from the :@0.559983:0.583171:0.919297:0.583171:0.919297:0.569166:0.559983:0.569166:0.005078:0.011118:0.006636:0.011118:0.011682:0.005029:0.011067:0.010434:0.007919:0.011067:0.011203:0.003421:0.003421:0.011682:0.011665:0.011203:0.005148:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.007919:0.011682:0.007919:0.005078:0.011118:0.011665:0.011203:0.005148:0.005790:0.007919:0.005371:0.005078:0.011203:0.016044:0.007919:0.005798:0.010434:0.011118:0.004738
Children’s Oncology Group. :@0.559983:0.597953:0.800901:0.597953:0.800901:0.583947:0.559983:0.583947:0.013906:0.010434:0.003421:0.003421:0.011716:0.005083:0.011118:0.010434:0.006004:0.006636:0.006568:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.006568:0.014915:0.005080:0.011203:0.010399:0.011665:0.004738:0.004738
Semin Oncol:@0.802731:0.597953:0.909822:0.597953:0.909822:0.583947:0.802731:0.583947:0.008518:0.011118:0.016044:0.003421:0.010434:0.006568:0.014864:0.010434:0.011067:0.011203:0.003421
. :@0.909822:0.597953:0.919297:0.597953:0.919297:0.583947:0.909822:0.583947:0.004738:0.004738
2008;35(5):484-93.:@0.559983:0.612734:0.706208:0.612734:0.706208:0.598729:0.559983:0.598729:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
6. :@0.523636:0.627515:0.542588:0.627515:0.542588:0.613510:0.523636:0.613510:0.009476:0.004738:0.004738
  Scheurer  ME,  Lupo  PJ,  Bondy  ML.  Epide-:@0.559983:0.627515:0.914534:0.627515:0.914534:0.613510:0.559983:0.613510:0.004738:-0.004738:0.008518:0.011067:0.010434:0.011118:0.010399:0.005073:0.011118:0.005148:0.004738:0.004312:0.015719:0.009168:0.004738:0.004738:0.004314:0.007902:0.010399:0.011665:0.011203:0.004738:0.004314:0.010126:0.008244:0.004738:0.004738:0.004310:0.009818:0.011203:0.010434:0.011716:0.009168:0.004738:0.004319:0.015719:0.007902:0.004738:0.004738:0.004312:0.009168:0.011665:0.003421:0.011716:0.011118:0.005679
miology of childhood cancer. In: Pizzo PA, :@0.559983:0.642297:0.919296:0.642297:0.919296:0.628292:0.559983:0.628292:0.016044:0.003421:0.011203:0.003421:0.011203:0.011511:0.009168:0.006483:0.011203:0.005371:0.006474:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.006474:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.006474:0.003866:0.010434:0.004738:0.006474:0.010126:0.003421:0.007269:0.007269:0.011203:0.006467:0.008853:0.012657:0.004738:0.004738
Poplack  DG, editors. :@0.559983:0.657078:0.740904:0.657078:0.740904:0.643073:0.559983:0.643073:0.010126:0.011203:0.011665:0.003421:0.011682:0.011067:0.008586:0.004738:0.003395:0.012726:0.014915:0.004738:0.008142:0.011118:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738
Principles and  Prac-:@0.744282:0.657078:0.914546:0.657078:0.914546:0.643073:0.744282:0.643073:0.010126:0.005148:0.003421:0.010434:0.011067:0.003421:0.011665:0.003421:0.011118:0.006636:0.008142:0.011682:0.010434:0.011716:0.004738:0.003394:0.010126:0.005148:0.011682:0.011067:0.005679
tice  of  Pediatric  Oncology:@0.559983:0.671860:0.788049:0.671860:0.788049:0.657854:0.559983:0.657854:0.005798:0.003421:0.011067:0.011118:0.004738:0.003169:0.011203:0.005371:0.004738:0.003166:0.010126:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.004738:0.003171:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
,  7th  ed.  Phila-:@0.788049:0.671860:0.914547:0.671860:0.914547:0.657854:0.788049:0.657854:0.004738:0.004738:0.003168:0.009476:0.005798:0.010434:0.004738:0.003169:0.011118:0.011716:0.004738:0.004738:0.003168:0.010126:0.010434:0.003421:0.003421:0.011682:0.005679
delphia (PA): Wolters Kluwer; 2016:2-9.:@0.559983:0.686641:0.871379:0.686641:0.871379:0.672636:0.559983:0.672636:0.011716:0.011118:0.003421:0.011665:0.010434:0.003421:0.011682:0.004738:0.006312:0.008860:0.012657:0.006312:0.004738:0.004738:0.015628:0.011203:0.003421:0.005798:0.011118:0.005148:0.006636:0.004738:0.010109:0.003421:0.010399:0.014214:0.011118:0.005148:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.005679:0.009476:0.004738
7. :@0.523636:0.701422:0.542588:0.701422:0.542588:0.687417:0.523636:0.687417:0.009476:0.004738:0.004738
  Curtin  SC,  Minino  AM,  Anderson  RN.  De-:@0.559983:0.701422:0.914544:0.701422:0.914544:0.687417:0.559983:0.687417:0.004738:-0.004738:0.013906:0.010399:0.005148:0.005798:0.003421:0.010434:0.004738:0.004245:0.008518:0.013906:0.004738:0.004738:0.004250:0.015719:0.003421:0.010434:0.003421:0.010434:0.011203:0.004738:0.004250:0.012657:0.015719:0.004738:0.004738:0.004245:0.012657:0.010434:0.011716:0.011109:0.005148:0.006636:0.011203:0.010434:0.004738:0.004245:0.010382:0.012657:0.004738:0.004738:0.004245:0.012726:0.011118:0.005679
clines in  cancer  death  rates  among  chil-:@0.559983:0.716204:0.914542:0.716204:0.914542:0.702199:0.559983:0.702199:0.011067:0.003421:0.003421:0.010434:0.011118:0.006636:0.008022:0.003421:0.010434:0.004738:0.003275:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.003269:0.011716:0.011118:0.011682:0.005798:0.010434:0.004738:0.003272:0.005148:0.011682:0.005798:0.011118:0.006636:0.004738:0.003272:0.011682:0.016044:0.011203:0.010434:0.011511:0.004738:0.003267:0.011067:0.010434:0.003421:0.003421:0.005679
dren and adolescents in the United States, :@0.559983:0.730985:0.919306:0.730985:0.919306:0.716980:0.559983:0.716980:0.011716:0.005078:0.011118:0.010434:0.005395:0.011682:0.010434:0.011716:0.005405:0.011682:0.011716:0.011203:0.003421:0.011118:0.006636:0.011067:0.011118:0.010434:0.005798:0.006636:0.005405:0.003421:0.010434:0.005405:0.005798:0.010434:0.011118:0.005391:0.011203:0.010434:0.003421:0.005798:0.011118:0.011716:0.005391:0.008518:0.005798:0.011682:0.005798:0.011118:0.006636:0.004738:0.004738
1999-2014. :@0.559983:0.745767:0.650944:0.745767:0.650944:0.731761:0.559983:0.731761:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
National Center for Health Sta-:@0.652825:0.745767:0.914549:0.745767:0.914549:0.731761:0.652825:0.731761:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.006602:0.013906:0.011118:0.010434:0.005798:0.011118:0.005148:0.006583:0.005371:0.011203:0.005148:0.006589:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.006594:0.008518:0.005798:0.011682:0.005679
tistics Data Brief. :@0.559983:0.760548:0.698477:0.760548:0.698477:0.746543:0.559983:0.746543:0.005798:0.003421:0.006636:0.005798:0.003421:0.011067:0.006636:0.004738:0.012726:0.011682:0.005798:0.011682:0.004738:0.009818:0.005148:0.003421:0.011118:0.005371:0.004738:0.004738
2016;257:1-8.:@0.698477:0.760548:0.803651:0.760548:0.803651:0.746543:0.698477:0.746543:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738:0.009476:0.005679:0.009476:0.004738
8. :@0.523636:0.775329:0.542588:0.775329:0.542588:0.761324:0.523636:0.761324:0.009476:0.004738:0.004738
  Jemal A, Ward EM, Johnson CJ, :@0.559983:0.775329:0.834248:0.775329:0.834248:0.761324:0.559983:0.761324:0.004738:-0.004738:0.008244:0.011118:0.016044:0.011682:0.003421:0.006508:0.012657:0.004738:0.006498:0.015568:0.011682:0.005044:0.011716:0.006506:0.009168:0.015719:0.004738:0.006505:0.008244:0.011203:0.010434:0.010434:0.006636:0.011203:0.010434:0.006493:0.013906:0.008244:0.004738:0.004738
et al:@0.836013:0.775329:0.874534:0.775329:0.874534:0.761324:0.836013:0.761324:0.011118:0.005798:0.006501:0.011682:0.003421
. An-:@0.874534:0.775329:0.914544:0.775329:0.914544:0.761324:0.874534:0.761324:0.004738:0.006503:0.012657:0.010434:0.005679
nual Report to the Nation on the status of :@0.559983:0.790111:0.919306:0.790111:0.919306:0.776105:0.559983:0.776105:0.010434:0.010399:0.011682:0.003421:0.006414:0.010382:0.011118:0.011665:0.011203:0.005148:0.005798:0.006402:0.005798:0.011203:0.006406:0.005798:0.010434:0.011118:0.006414:0.012657:0.011682:0.005798:0.003421:0.011203:0.010434:0.006404:0.011203:0.010434:0.006406:0.005798:0.010434:0.011118:0.006414:0.006636:0.005798:0.011682:0.005798:0.010399:0.006636:0.006414:0.011203:0.005371:0.004738
cancer, 1975-2014, featuring survival. :@0.559983:0.804892:0.872377:0.804892:0.872377:0.790887:0.559983:0.790887:0.011067:0.011682:0.010434:0.011067:0.011118:0.003346:0.004738:0.006226:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009500:0.009476:0.004738:0.006226:0.005371:0.011118:0.011682:0.005798:0.010399:0.005148:0.003421:0.010434:0.011511:0.006226:0.006636:0.010399:0.005148:0.009476:0.003421:0.009476:0.011682:0.003421:0.004738:0.004738
Jour-:@0.873882:0.804892:0.914539:0.804892:0.914539:0.790887:0.873882:0.790887:0.008244:0.011203:0.010399:0.005131:0.005679
nal of the National Cancer Institute.:@0.559983:0.819674:0.865100:0.819674:0.865100:0.805668:0.559983:0.805668:0.010434:0.011682:0.003421:0.006808:0.011203:0.005371:0.006799:0.005798:0.010434:0.011118:0.006796:0.012657:0.011682:0.005798:0.003421:0.011203:0.010425:0.011682:0.003421:0.006808:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.006796:0.003866:0.010434:0.006636:0.005798:0.003421:0.005798:0.010399:0.005798:0.011118:0.004738
 2017; :@0.865100:0.819674:0.919287:0.819674:0.919287:0.805668:0.865100:0.805668:0.006808:0.009476:0.009476:0.009476:0.009476:0.004738:0.004738
109(9).:@0.559983:0.834455:0.615247:0.834455:0.615247:0.820450:0.559983:0.820450:0.009476:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738
9. :@0.523636:0.849236:0.542588:0.849236:0.542588:0.835231:0.523636:0.835231:0.009476:0.004738:0.004738
  Warren KE. Diffuse intrinsic pontine glioma: :@0.559983:0.849236:0.919284:0.849236:0.919284:0.835231:0.559983:0.835231:0.004738:-0.004738:0.015568:0.011682:0.005148:0.005075:0.011118:0.010434:0.006110:0.010109:0.009168:0.004738:0.006110:0.012726:0.003421:0.005424:0.005371:0.010399:0.006636:0.011118:0.006113:0.003421:0.010434:0.005798:0.005148:0.003421:0.010434:0.006636:0.003421:0.011067:0.006115:0.011665:0.011203:0.010434:0.005798:0.003421:0.010434:0.011118:0.006108:0.011511:0.003421:0.003421:0.011203:0.016044:0.011682:0.004738:0.004738
poised for progress. :@0.559983:0.864018:0.729776:0.864018:0.729776:0.850012:0.559983:0.850012:0.011665:0.011203:0.003421:0.006636:0.011118:0.011716:0.006961:0.005371:0.011203:0.005148:0.006951:0.011665:0.005080:0.011203:0.011511:0.005071:0.011118:0.006636:0.006636:0.004738:0.004738
Frontiers in Oncology.:@0.731999:0.864018:0.914568:0.864018:0.914568:0.850012:0.731999:0.850012:0.008296:0.005148:0.011203:0.010434:0.005798:0.003421:0.011118:0.005148:0.006636:0.006941:0.003421:0.010434:0.006961:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738
 :@0.914539:0.864018:0.919277:0.864018:0.919277:0.850012:0.914539:0.850012:0.004738
2012;2:205.:@0.559983:0.878799:0.650003:0.878799:0.650003:0.864794:0.559983:0.864794:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738
10.   Triche TJ, Hicks MJ, Sorensen PH. Diagnos-:@0.523636:0.893580:0.914551:0.893580:0.914551:0.879575:0.523636:0.879575:0.009476:0.009476:0.004738:0.004738:0.007919:0.000000:0.006773:0.005148:0.003421:0.011067:0.010434:0.011118:0.006979:0.007286:0.008244:0.004738:0.006979:0.011682:0.003421:0.011067:0.008586:0.006636:0.006979:0.015719:0.008244:0.004738:0.006979:0.008518:0.011203:0.005075:0.011118:0.010434:0.006636:0.011118:0.010434:0.006979:0.010126:0.011682:0.004738:0.006979:0.012726:0.003421:0.011682:0.011511:0.010434:0.011203:0.006636:0.005679
tic pathology of pediatric malignancies. :@0.559983:0.907774:0.919294:0.907774:0.919294:0.893769:0.559983:0.893769:0.005798:0.003421:0.011067:0.010246:0.011665:0.011682:0.005798:0.010434:0.011203:0.003421:0.011203:0.011511:0.009168:0.010246:0.011203:0.005371:0.010246:0.011665:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.010246:0.016044:0.011682:0.003421:0.003421:0.011511:0.010434:0.011682:0.010434:0.011067:0.003421:0.011118:0.006636:0.004738:0.004738
In:  Pizzo  PA,  Poplack DG, editors. :@0.559983:0.921967:0.859879:0.921967:0.859879:0.907962:0.559983:0.907962:0.003866:0.010434:0.004738:0.004738:0.005395:0.010126:0.003421:0.007269:0.007269:0.011203:0.004738:0.005391:0.008852:0.012657:0.004738:0.004738:0.005391:0.010126:0.011203:0.011665:0.003421:0.011682:0.011067:0.008586:0.010143:0.012726:0.014915:0.004738:0.010143:0.011118:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738
Princi-:@0.865244:0.921967:0.914539:0.921967:0.914539:0.907962:0.865244:0.907962:0.010126:0.005148:0.003421:0.010434:0.011067:0.003421:0.005679
ples and Practice of Pediatric Oncology:@0.559983:0.936161:0.909818:0.936161:0.909818:0.922155:0.559983:0.922155:0.011665:0.003421:0.011118:0.006636:0.008159:0.011682:0.010434:0.011716:0.008159:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.008159:0.011203:0.005371:0.008159:0.010126:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.008159:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
, :@0.909818:0.936161:0.919294:0.936161:0.919294:0.922155:0.909818:0.922155:0.004738:0.004738